Search results
Opinion | Why Oprah’s medical weight loss message is still so muddled
MSNBC via Yahoo News· 6 days agoWhat's the "best" way to lose diet? Ozempic, Wegovy, Zepbound and Mounjaro have made weight loss...
Could mandating nutrition labels on the front of food packages lower obesity rates?
NBC Universal via AOL· 7 days agoThe Food and Drug Administration is expected to propose a change to prepackaged food sold in America...
Anti-obesity drugs will be 2024’s defining trend
Clinical Trials Arena via Yahoo Finance· 3 days agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence,and cell and gene therapies.
Why Home-Builder Stocks Can Continue Their Bull Run
Barrons.com· 10 hours agoHome inventory is up, but still very low and prices remain high. That means builder profits should remain fat. Plus, exploiting the rush to obesity...
Palatin Technologies commences Phase II study of obesity treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoPalatin Technologies has commenced a Phase II clinical trial of breatelanotide, a melanocortin 4...
Novo’s blockbuster obesity drug Wegovy under fire in Denmark
Detroit News· 2 days agodrug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s blockbuster ...
Jesse Plemons addresses ‘unfortunate’ Ozempic rumors amid his weight loss journey
The Independent via Yahoo News· 11 hours agoWegovy is another semaglutide injection specifically approved for the treatment of obesity and...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 3 days agoTo join the $1 trillion market capitalization club, it will need help from the bench — including an...
Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening
Charlotte Observer via Yahoo Finance· 18 hours agoAbout Eli Lilly Eli Lilly is known for producing obesity and diabetes drugs, including Jardiance,...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 3 days agoStill, it’s certainly not bad...Chen wrote Monday. It’s even more significant for Biogen and Eisai....